A new study found that stimulating CB2, a receptor involved in immune cell function, improved cognitive performance in Alzheimer's disease (AD) mouse models. Researchers showed that activating CB2 ...

Past research has shown that activating CB1 and CB2 receptors with plant-derived compounds can slow down early tumor growth in various cancers, as they act as mediators, triggering different ...

VANCOUVER - In a significant development for its proprietary small molecule drug candidates, InMed Pharmaceuticals Inc.

An F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. patent details new cannabinoid CB2 receptor modulators reported to be useful for the treatment of neuropathic pain, asthma, osteoporosis, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

InMed Pharmaceuticals Inc., a pharmaceutical company focusing on developing small molecule drug candidates for high unmet medical needs, recently announced the granting of an international Patent ...

Marks the first jurisdictional issuance of an international patent for a family of novel small molecule compounds. Patent ...